US Pharma MarketingScaling cell and gene therapy for broader clinical adoption
Scaling cell and gene therapy for broader clinical adoption is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Inside CGT’s shift to mainstream care—and the zero tolerance logistics required to get there.
Source: FiercePharma